Skip to main content

Table 3 Individual tumor and kidney AUC predictions versus observations for [177Lu]Lu-HA-DOTATATE, followed by calculated RPEs per patient (ID2–ID10)

From: Predicting [177Lu]Lu-HA-DOTATATE kidney and tumor accumulation based on [68Ga]Ga-HA-DOTATATE diagnostic imaging using semi-physiological population pharmacokinetic modeling

AUC0-tlast (mg*h/L)

ID2

ID3

ID4

ID5

ID6

ID7

ID8

ID9

ID10

Tumor

 Observed

3.32

2.09

5.29

4.69

1.38

2.80

2.94

1.76

2.59

 Predicted

2.95

2.67

4.05

2.89

0.825

3.06

3.16

1.50

2.60

 RPE

−11%

28%

−23%

−38%

−40%

9%

8%

−14%

0%

Kidney

 Observed

–

0.520

0.634

0.334

0.902

0.564

0.443

0.764

0.621

 Predicted

–

0.533

0.680

0.469

0.408

0.479

0.410

0.496

0.426

 RPE

–

4%

14%

41%

−53%

−12%

−10%

−32%

−32%

  1. AUC0-tlast, area under the curve, calculated from time is 0 to time of the last measurement; RPE, relative prediction error (((predicted – observed)/observed) * 100%)